rss
Br J Ophthalmol 1990;74:663-664 doi:10.1136/bjo.74.11.663
  • Research Article

Topical timolol and serum lipoproteins.

  1. J West and
  2. S Longstaff
  1. Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield.

      Abstract

      Oral timolol taken for the treatment of systemic hypertension has been shown to affect adversely serum lipoprotein levels. In a 15-week study on 19 patients topical timolol therapy for raised intraocular pressure was found to have no significant adverse effect on serum lipoprotein levels. This is reassuring in view of the large number of patients on this form of long term therapy, and selection of the type of beta blocker to use should not be influenced by lipid changes associated with the oral form of the drug.

      This Article

      1. Abstract
      2. PDF

      Responses

      1. Submit a response
      2. No responses published

      Social bookmarking

      Register for free content


      Free sample
       This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
      View free sample issue >>

      Free archive
      The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.